acetamidomethylboronic acid

ID: ALA227673

Chembl Id: CHEMBL227673

Cas Number: 497258-71-6

PubChem CID: 9898816

Max Phase: Preclinical

Molecular Formula: C3H8BNO3

Molecular Weight: 116.91

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Acetamidomethylboronic Acid | (acetamidomethyl)boronic acid|Acetamidomethylboronic Acid|497258-71-6|CHEMBL227673|Acylglycineboronic acid, 5|(acetamidomethyl)boronicacid|C3H8BNO3|LP03|BDBM50202233|AKOS006291354|EN300-134747|Z1198183387

Canonical SMILES:  CC(=O)NCB(O)O

Standard InChI:  InChI=1S/C3H8BNO3/c1-3(6)5-2-4(7)8/h7-8H,2H2,1H3,(H,5,6)

Standard InChI Key:  NMDBCQJRADLOIC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

Associated Targets(non-human)

bla Beta-lactamase SHV-1 (99 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
shv5 SHV-5 extended spectrum beta-lactamase (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dac D-alanyl-D-alanine carboxypeptidase (132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pbpX Penicillin-binding protein 2X (99 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pbpX Penicillin-binding protein 2x (156 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 116.91Molecular Weight (Monoisotopic): 117.0597AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Thomson JM, Prati F, Bethel CR, Bonomo RA..  (2007)  Use of novel boronic acid transition state inhibitors to probe substrate affinity in SHV-type extended-spectrum beta-lactamases.,  51  (4): [PMID:17220410] [10.1128/aac.01293-06]
2. Morandi S, Morandi F, Caselli E, Shoichet BK, Prati F..  (2008)  Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors.,  16  (3): [PMID:17997318] [10.1016/j.bmc.2007.10.075]
3. Eidam O, Romagnoli C, Caselli E, Babaoglu K, Pohlhaus DT, Karpiak J, Bonnet R, Shoichet BK, Prati F..  (2010)  Design, synthesis, crystal structures, and antimicrobial activity of sulfonamide boronic acids as β-lactamase inhibitors.,  53  (21): [PMID:20945905] [10.1021/jm101015z]
4. Zervosen A, Bouillez A, Herman A, Amoroso A, Joris B, Sauvage E, Charlier P, Luxen A..  (2012)  Synthesis and evaluation of boronic acids as inhibitors of Penicillin Binding Proteins of classes A, B and C.,  20  (12): [PMID:22579615] [10.1016/j.bmc.2012.04.018]
5. Trippier PC, McGuigan C.  (2010)  Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications,  (3): [10.1039/C0MD00119H]

Source